Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard G Harris

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Urology|April 11, 2020
"PSA Surveillance in the Septuagenarian": A Proposed New Terminology for Clinical Follow-up to Assess Risk of Prostate Cancer in Men Aged 70 Years and OlderSigrid V Carlsson, James A Eastham, E David Crawford, et al.
The Prostate|March 5, 2020
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelinesNeal D Shore, Emmanuel S Antonarakis, Michael S Cookson, et al.
The Journal of Urology|October 22, 2020
Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical DataE David Crawford, Jason M Hafron, Scott T Tagawa, et al.
The Journal of Urology|October 4, 2019
The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical DataE David Crawford, Przemyslaw W Twardowski, Raoul S Concepcion, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Urology|April 11, 2020
"PSA Surveillance in the Septuagenarian": A Proposed New Terminology for Clinical Follow-up to Assess Risk of Prostate Cancer in Men Aged 70 Years and OlderSigrid V Carlsson, James A Eastham, E David Crawford, et al.
The Prostate|March 5, 2020
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelinesNeal D Shore, Emmanuel S Antonarakis, Michael S Cookson, et al.
The Journal of Urology|October 22, 2020
Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical DataE David Crawford, Jason M Hafron, Scott T Tagawa, et al.
The Journal of Urology|October 4, 2019
The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical DataE David Crawford, Przemyslaw W Twardowski, Raoul S Concepcion, et al.
Pageof 1